Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting

Trial ID or NCT#

NCT01492569

Status

not recruiting iconNOT RECRUITING

Purpose

This randomized pilot clinical trial studies giving acupuncture in reducing nausea and vomiting in patients undergoing chemotherapy. Pressing and stimulating nerves at an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy.

Official Title

Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting

Eligibility Criteria

Ages Eligible for Study: 8 Years to 21 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Patient with a planned admission for at least 24 hours for highly emetogenic or moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard El Camino.* Planned to undergo at least 2 more cycles of chemotherapy.* Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma, Osteosarcoma* History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at minimum) despite use of conventional antiemetic medications.* Age 8-21.* Parent must be able to understand and willing to sign written informed consent document.
Exclusion Criteria:
  1. * Prior knowledge of acupuncture or experience with acupuncture or acupressure.* There will be no restrictions regarding use of other Investigational Agents.* Comorbid Diseases:
  2. * Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker placement). * Any diagnosis requiring pediatric intensive care unit admission. * Patients with brain tumor, brain metastasis (these patients often require radiation and surgery in addition to chemotherapy which may confound the results) * Concomitant radiation therapy during current chemotherapy cycle. * Developmental delay patients with allergy to tape or leads will be excluded from the study.* Pregnant patients will be excluded from the study.* Cancer survivors will not be excluded from the study as long as they are undergoing chemotherapy treatment for their current cancer therapy.* HIV-positive patients will not be excluded.
View All Criteria
Show Less

Investigator(s)

Brenda Golianu
Brenda Golianu
Pain management specialist, Anesthesiologist
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)

Contact us to find out if this trial is right for you.

Contact

Brenda Golianu
650-723-5728

View on ClinicalTrials.gov